Morpholino

MO2-sil1

ID

ZDB-MRPHLNO-170718-4

Name

MO2-sil1

Previous Names

None

Target

Sequence

5' - GGTGACTGTGTAAACAGAACAAATC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

splicing MO

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO2-sil1

Expressed Gene	Anatomy	Figures
cldnk	myelinating Schwann cell	Fig. 6 from Phan et al., 2018
dag1	myoseptum	Fig. 3 from Kawahara et al., 2016

Phenotype

Phenotype resulting from MO2-sil1

Phenotype	Fish	Figures
apoptotic process increased occurrence, abnormal	AB + MO2-sil1	Fig. 6 from Kawahara et al., 2016
eye decreased diameter, abnormal	AB + MO2-sil1	Fig. 4 from Kawahara et al., 2016
eye decreased size, abnormal	AB + MO2-sil1	Fig. 4 from Kawahara et al., 2016
myoseptum morphology, abnormal	AB + MO2-sil1	Fig. 3 from Kawahara et al., 2016
myoseptum dag1 expression spatial pattern, abnormal	AB + MO2-sil1	Fig. 3 from Kawahara et al., 2016
Purkinje cell decreased amount, abnormal	AB + MO2-sil1	Fig. 5 from Kawahara et al., 2016
skeletal muscle morphology, abnormal	AB + MO2-sil1	Fig. 2 from Kawahara et al., 2016
skeletal muscle refractivity, abnormal	AB + MO2-sil1	Fig. 2 from Kawahara et al., 2016
skeletal muscle fiber development disrupted, abnormal	AB + MO2-sil1	Fig. 3 from Kawahara et al., 2016

Phenotype of all Fish created by or utilizing MO2-sil1

Phenotype	Fish	Conditions	Figures
skeletal muscle morphology, abnormal	AB + MO2-sil1	standard conditions	Fig. 2 from Kawahara et al., 2016
skeletal muscle refractivity, abnormal	AB + MO2-sil1	standard conditions	Fig. 2 from Kawahara et al., 2016
myoseptum dag1 expression spatial pattern, abnormal	AB + MO2-sil1	standard conditions	Fig. 3 from Kawahara et al., 2016
myoseptum morphology, abnormal	AB + MO2-sil1	standard conditions	Fig. 3 from Kawahara et al., 2016
eye decreased diameter, abnormal	AB + MO2-sil1	standard conditions	Fig. 4 from Kawahara et al., 2016
Purkinje cell decreased amount, abnormal	AB + MO2-sil1	standard conditions	Fig. 5 from Kawahara et al., 2016
skeletal muscle fiber development disrupted, abnormal	AB + MO2-sil1	standard conditions	Fig. 3 from Kawahara et al., 2016
eye decreased size, abnormal	AB + MO2-sil1	standard conditions	Fig. 4 from Kawahara et al., 2016
apoptotic process increased occurrence, abnormal	AB + MO2-sil1	standard conditions	Fig. 6 from Kawahara et al., 2016
motor neuron presynapse ab-sv2 labeling spatial pattern, abnormal	slc24a5^b1/b1 + MO2-sil1	standard conditions	Fig. 6 from Phan et al., 2018
vertical myoseptum synapse assembly disrupted, abnormal	slc24a5^b1/b1 + MO2-sil1	standard conditions	Fig. 6 from Phan et al., 2018

Citations